Disease-modifying therapeutic strategies in osteoarthritis: current status and future directions

Y Cho, S Jeong, H Kim, D Kang, J Lee… - … & molecular medicine, 2021 - nature.com
Osteoarthritis (OA) is the most common form of arthritis. It is characterized by progressive
destruction of articular cartilage and the development of chronic pain and constitutes a …

A perspective on the kinetics of covalent and irreversible inhibition

JM Strelow - SLAS Discovery: Advancing Life Sciences R&D, 2017 - journals.sagepub.com
The clinical and commercial success of covalent drugs has prompted a renewed and more
deliberate pursuit of covalent and irreversible mechanisms within drug discovery. A covalent …

Recent advances in biocatalysis with chemical modification and expanded amino acid alphabet

AD Pagar, MD Patil, DT Flood, TH Yoo… - Chemical …, 2021 - ACS Publications
The two main strategies for enzyme engineering, directed evolution and rational design,
have found widespread applications in improving the intrinsic activities of proteins. Although …

Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer

T Shree, OC Olson, BT Elie, JC Kester… - Genes & …, 2011 - genesdev.cshlp.org
The microenvironment is known to critically modulate tumor progression, yet its role in
regulating treatment response is poorly understood. Here we found increased macrophage …

Irreversible inhibitors of serine, cysteine, and threonine proteases

JC Powers, JL Asgian, ÖD Ekici, KE James - Chemical reviews, 2002 - ACS Publications
Proteases or proteolytic enzymes form one of the largest and more important groups of
enzymes. Proteases selectively catalyze the hydrolysis of peptide bonds and can be divided …

Multiple cathepsins promote pro–IL-1β synthesis and NLRP3-mediated IL-1β activation

GM Orlowski, JD Colbert, S Sharma… - The Journal of …, 2015 - journals.aai.org
Sterile particles induce robust inflammatory responses that underlie the pathogenesis of
diseases like silicosis, gout, and atherosclerosis. A key cytokine mediating this response is …

Lysosomes and lysosomal cathepsins in cell death

U Repnik, V Stoka, V Turk, B Turk - … et Biophysica Acta (BBA)-Proteins and …, 2012 - Elsevier
Lysosomes are the key degradative compartments of the cell. Lysosomal cathepsins, which
are enclosed in the lysosomes, help to maintain the homeostasis of the cell's metabolism by …

Inhibition of NGLY1 inactivates the transcription factor Nrf1 and potentiates proteasome inhibitor cytotoxicity

FM Tomlin, UIM Gerling-Driessen, YC Liu… - ACS central …, 2017 - ACS Publications
Proteasome inhibitors are used to treat blood cancers such as multiple myeloma (MM) and
mantle cell lymphoma. The efficacy of these drugs is frequently undermined by acquired …

Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis

JA Joyce, A Baruch, K Chehade, N Meyer-Morse… - Cancer cell, 2004 - cell.com
Tumors develop through successive stages characterized by changes in gene expression
and protein function. Gene expression profiling of pancreatic islet tumors in a mouse model …

[图书][B] Peptides: chemistry and biology

N Sewald, HD Jakubke - 2015 - books.google.com
Der" Sewald/Jakubke" ist und bleibt das einzige moderne, auf dem neuesten
wissenschaftlichen Stand gehaltene fortgeschrittene Lehrbuch der Peptid-Biochemie! Auch …